Oct/20/2009 08:20
The words that
marketers love to hear "consumers choice". Since
there is no real clinical evidence to
differentiate Levitra, Cialis and Viagra they
suggested that physicians leave it up to patients
and what they can afford or what their health
plans recommend as a first line treatment for
ED. Read
More...
Tags: ED Drugs
Oct/17/2009 11:21
What is of value
to patients and consumers? How about a
teleconference with a health care professional on
ITP? GSK is launching a series of teleconferences
with a health care professional to discuss ITP
via their unbranded site Low Platelets.com. This
is a great way to engage the ITP community and
offer a chance to discuss ITP with a certified
ITP expert. Read
More...
Tags: ITP
Oct/13/2009 05:55
Afresa, insulin
powder that is inhaled into the lungs, is
currently before the FDA awaiting approval. The
use of insulin in an inhaled form is not new. It
was introduced by Pfizer with a product called
Exubera in 2006. But Exubera was pounced on by
influential social media bloggers who talked
about the damage the product caused to the lungs.
They kept people from trying the product and it
was withdrawn less than two years after federal
approval. If Afresa is going to get approval they
could do themselves a favor by learning the
lessons of ignoring the power of social
media. Read
More...
Tags: Social Media
Oct/12/2009 10:31
I love the fall.
Time for NFL football, the baseball playoffs and
a lot of ads for Viagra, Cialis and Levitra. If
you're a man and you haven't heard of ED, or one
of the branded prescription ED drugs, than you
obviously live in a cave without any media. The
latest campaign from Viagra tries to address the
major barrier of having the initial discussion
with your doctor but frankly this TV spot is not
going to do much to get men to "have the
conversation". Read
More...
Tags: Viagra
Oct/05/2009 06:22
Pfizer is out
seeking fresh thinking on Viagra. Pfizer devoted
$121 million to U.S. measured media for Viagra in
2008, and $57 million for the first half of 2009,
according to TNS Media Intelligence and Viagra
still has a wide lead over rivals Cialis and
Levitra and Viagra.com draws a hell of a lot more
people than any other prescription ED site. Still
perhaps Viagra is looking to increase share with
men who are resistant to "the conversation" with
their doctor. Read
More...
Tags: Viagra
Sep/23/2009 04:03
Be afraid..be
very afraid ! Amgen is getting ready to launch
their osteoporosis drug later this year and they
have already started some premliminary marketing
with an unbranded site knowmybones.com. The FDA did
their best to handcuff Amgen's new drug but if
they are marketing savvy it could be a winner
but their unbranded sites shows that they have
a lot of work to do. Read
More...
Tags: Amgen
